SCHEMBL20054814

SCHEMBL20054814

Nc1ccc(SNc2ccccn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
GAA P10253 3/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
MEN1 O00255 1/20 0.41
MAPK10 P53779 1/20 0.41
GFER P55789 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ALPL P05186 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11287260 0.85 GAA (0.50) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL24938161 0.82 RAB9A (0.47) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL11294798 0.82 KDM4E (0.51) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL19345853 0.79 TSHR (0.44) SMN1; SMN2ALDH1A1LMNAMAPTMAOA
SCHEMBL8562167 0.79 GAA (0.45) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL11293577 0.78 ALDH1A1 (0.52) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL19699329 0.78 ALDH1A1 (0.46) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL5674801 0.73 EHMT2 (0.52) SMN1; SMN2GAAALDH1A1LMNAMAPT
SCHEMBL3888498 0.72 MEN1 (0.55) SMN1; SMN2GAAALDH1A1MAPTMAOA
SCHEMBL29590223 0.72 MEN1 (0.55) SMN1; SMN2GAAALDH1A1MAPTMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150197-A1 ARYL HYDROCARBON RECEPTOR AGONISTS AND USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2023-08-10 WO disclosed
WO-2019183523-A1 HETERO-BIFUNCTIONAL DEGRADER COMPOUNDS AND THEIR USE AS MODULATORS OF TARGETED UBIQUINATION (VHL) GENENTECH, INC. (US) 2019-09-26 WO disclosed
EP-3437641-A1 INFLAMMATORY INTESTINAL DISEASE THERAPEUTIC AGENT DAIICHI SANKYO COMPANY, LIMITED (JP) 2019-02-06 EP disclosed
EP-2863921-B1 POLYMER-NSAID CONJUGATE POLYACTIVA PTY LTD (AU) 2018-04-18 EP disclosed